BIOASTER est partenaire du prochain Forum Santé Innovation #FSI qui se tiendra le 27 avril 2021 à Lyon au Musée des Confluences. Inscription gratuite! Informations et Inscriptions: Site du Forum...
Elle est le fruit de l’union d’une quinzaine d’acteurs publics et privés engagés (instituts de recherche, entreprises, pôles de compétitivité), elle vise à promouvoir l’écosystème français impliqué dans la science...
Profitez d’une opportunité unique pour faire valoir vos idées, vos projets, vos besoins et remettre le sujet des maladies infectieuses émergentes au cœur des sujets santé en France ! TPE,...
Hopefully, we will have a chance to share updates face to face, in the meantime we are happy to highlight some of the 2020 Antimicrobials Program achievements. If this should...
LUMI-Seq®: Nouvelle vidéo en ligne Découvrez la nouvelle vidéo technologie Designed BY BIOASTER sur la technologie LUMI-Seq® : Une nouvelle approche de séquençage ciblé permettant la génération de longues séquences...
A la demande de la Préfecture, le @SDMIS69 –Service Départemental et Métropolitain d’Incendie et de Secours- conjointement avec la Police Nationale @PoliceNat69, a procédé jeudi 7 janvier à un exercice...
BIOASTER, Université de Technologie de Compiègne, Hospices Civils de Lyon and bioMérieux formalize strategic collaboration to conduct Next Generation Sequencing technology evaluation in microbiology Lyon, December 2, 2020 – BIOASTER...
Inscrivez vous à la 4ème édition du congrès Immunotherapies & Innovations for Infectious Diseases! Les 9 et 10 décembre 2020. Cette année la conférence sera donné uniquement à distance et...
Open Call: Apply for TRANSVAC2 Vaccine Development Services Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at...
Inscriptions au prochain congrès I4ID 2020La fin des inscriptions early bird repoussée au 30 Octobre! Inscriptions, Programme et information sponsor: https://www.i4id.org/ Depêchez vous!
PRE-PRINT COVID19 : Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19 Authors:...
By continuing browsing this website, you accept the use of cookies or other tracers for statistics of visits to optimize the functionality of the site, and or privacy policy. AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
